David Hsieh

David Hsieh, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center, specializing in Hematology and Oncology. He leads clinical trials for liver cancers, including hepatocellular carcinoma and cholangiocarcinoma, and investigates mechanisms of cancer therapy resistance and treatment biomarkers. His work also addresses biases and processes in scientific research and healthcare policy.

Education:

• Medical Degree: University of Arizona College of Medicine
• Residency: Internal Medicine at Mount Auburn Hospital
• Fellowship: Hematology and Oncology at UT Southwestern Medical Center

Research Interests:

Focuses on translational research in liver cancers, including drug efficacy mechanisms, biomarker development, and clinical trial innovations. Explores systemic biases in oncology trials and healthcare policies affecting drug coverage and accessibility. Engages in investigating racial disparities in cancer outcomes and mutation patterns.

Scientific Awards:

• Early Career Investigator Award, Cancer Prevention and Research Institute of Texas

Advising & Grants:

Active in clinical trial design and leadership, though specific advising or grant details are not explicitly listed. Collaborates on high-impact trials like IMbrave150 and IMbrave050.

Lab/Teams:

Member of the Division of Hematology and Oncology at UT Southwestern, contributing to both clinical care and translational research initiatives.